Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2009; 33: 443-444 Year: 2009
Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
Negative clinical trials in sarcoidosis: failed therapies or flawed study design? Source: Eur Respir J 2014; 44: 1123-1126 Year: 2014
From clinical trials to real-world data: New dimensions of patient benefits Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights Year: 2015
The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017
Large trials, new knowledge: the changing face of COPD management Source: Eur Respir J 2015; 45: 1692-1703 Year: 2015
Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019
MDR-/XDR-TB: what are the unresolved problems in the clinical management? Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET) Year: 2012
Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008
(Non-)sense to interpret meta-analyses with heterogeneous interventions: the example of non-pharmacological interventions Source: International Congress 2015 – How to perform and interpret systematic reviews and meta-analyses Year: 2015
Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2008; 31: 927-933 Year: 2008
Asthma quality of life in clinical trials - can we combine data from different countries? Source: Eur Respir J 2001; 18: Suppl. 33, 4s Year: 2001
Thoracic oncology, this journal club will explore a major randomised trial in mesothelioma treatment, implications for practice and the strengths and weaknesses of the study in the context of the published data Source: Journal Club 2022 Year: 2022
The pharmacoepidemiology of COPD: Recent advances and methodological discussion Source: Eur Respir J 2003; 22: 1S-44S Year: 2003
Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007
From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control Source: Annual Congress 2013 –The best of TB PANNET Year: 2013
Translating trials to clinical practice: results ²more real than real life itself²¹ Source: Annual Congress 2007 - Smoking cessation Year: 2007